The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Kimberly L. Blackwell

Department of Medicine/Medical Oncology

Box 3893

Duke University Medical Center

Durham

[email]@mc.duke.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine/Medical Oncology, Box 3893, Duke University Medical Center, Durham. 2004 - 2012
  • Duke University Medical Center, Durham, NC 27701, USA. 2010
  • Division of Medical Oncology, Department of Medicine, Duke University Comprehensive Cancer Center, Erwin Road, USA. 2003 - 2004
  • Duke University Comprehensive Cancer Center, Durham, North Carolina, USA. 2004

References

  1. Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study. Blackwell, K.L., Burstein, H.J., Storniolo, A.M., Rugo, H.S., Sledge, G., Aktan, G., Ellis, C., Florance, A., Vukelja, S., Bischoff, J., Baselga, J., O'Shaughnessy, J. J. Clin. Oncol. (2012) [Pubmed]
  2. Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer. Blackwell, K.L., Burstein, H.J., Storniolo, A.M., Rugo, H., Sledge, G., Koehler, M., Ellis, C., Casey, M., Vukelja, S., Bischoff, J., Baselga, J., O'Shaughnessy, J. J. Clin. Oncol. (2010) [Pubmed]
  3. Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens. Blackwell, K.L., Pegram, M.D., Tan-Chiu, E., Schwartzberg, L.S., Arbushites, M.C., Maltzman, J.D., Forster, J.K., Rubin, S.D., Stein, S.H., Burstein, H.J. Ann. Oncol. (2009) [Pubmed]
  4. HER-2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors. Blackwell, K.L., Dewhirst, M.W., Liotcheva, V., Snyder, S., Broadwater, G., Bentley, R., Lal, A., Riggins, G., Anderson, S., Vredenburgh, J., Proia, A., Harris, L.N. Clin. Cancer Res. (2004) [Pubmed]
  5. Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Blackwell, K., Hurwitz, H., Liebérman, G., Novotny, W., Snyder, S., Dewhirst, M., Greenberg, C. Cancer (2004) [Pubmed]
  6. rHuEPO and improved treatment outcomes: potential modes of action. Blackwell, K., Gascón, P., Sigounas, G., Jolliffe, L. Oncologist (2004) [Pubmed]
  7. Human recombinant erythropoietin significantly improves tumor oxygenation independent of its effects on hemoglobin. Blackwell, K.L., Kirkpatrick, J.P., Snyder, S.A., Broadwater, G., Farrell, F., Jolliffe, L., Brizel, D.M., Dewhirst, M.W. Cancer Res. (2003) [Pubmed]
 
WikiGenes - Universities